Researchers demonstrated that an anticorisin monoclonal antibody ameliorated lung fibrosis by significantly inhibiting acute exacerbation in the human transforming growth factorβ1 model and acute lung injury in the bleomycin model.
[Nature Communications]
Sorry, but the selected Zotpress account can't be found.
